Abstract

Acute and chronic ethanol administration increase autophagic vacuole (i.e., autophagosome; AV) content in liver cells. This enhancement depends on ethanol oxidation. Here, we used parental (nonmetabolizing) and recombinant (ethanolmetabolizing) Hep G2 cells to identify the ethanol metabolite that causes AV enhancement by quantifying AVs or their marker protein, microtubule-associated protein 1 light chain 3-I (LC3-II). The ethanol-elicited rise in LC3-II was dependent on ethanol dose, was seen only in cells that expressed alcohol dehydrogenase (ADH) and was augmented in cells that coexpressed cytochrome CYP2E1 (P450 2E1). Furthermore, the rise in LC3-II was inversely related to a decline in proteasome activity. AV flux measurements and colocalization of AVs with lysosomes or their marker protein Lysosomal-Associated Membrane Protein 1 (LAMP1) in ethanol-metabolizing VL-17A cells (ADH+/CYP2E1+) revealed that ethanol exposure not only enhanced LC3-II synthesis but also decreased its degradation. Ethanol-induced accumulation of LC3-II in these cells was similar to that induced by the microtubule inhibitor, nocodazole. After we treated cells with either 4-methylpyrazole to block ethanol oxidation or GSH-EE to scavenge reactive species, there was no enhancement of LC3-II by ethanol. Furthermore, regardless of their ethanol-metabolizing capacity, direct exposure of cells to acetaldehyde enhanced LC3-II content. We conclude that both ADH-generated acetaldehyde and CYP2E1-generated primary and secondary oxidants caused LC3-II accumulation, which rose not only from enhanced AV biogenesis, but also from decreased LC3 degradation by the proteasome and by lysosomes.

Original languageEnglish (US)
Pages (from-to)63-73
Number of pages11
JournalAutophagy
Volume9
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Hep G2 Cells
Ethanol
Cytochrome P-450 CYP2E1
Alcohol Dehydrogenase
Acetaldehyde
Proteasome Endopeptidase Complex
Lysosomes
Lysosomal-Associated Membrane Protein 1
Autophagosomes
Nocodazole
Microtubule-Associated Proteins
Vacuoles
Oxidants
Microtubules
Proteins
Light

Keywords

  • Acetaldehyde
  • Alcohol dehydrogenase
  • Autophagy
  • Cytochrome P450 2E1
  • Lysosome
  • Oxidant stress

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Multilevel regulation of autophagosome content by ethanol oxidation in HepG2 cells. / Thomes, Paul G; Ehlers, Rebecca A.; Trambly, Casey S.; Clemens, Dahn L; Fox, Howard S; Tuma, Dean J.; Donohue, Terrence.

In: Autophagy, Vol. 9, No. 1, 01.2013, p. 63-73.

Research output: Contribution to journalArticle

@article{5ef247fdfddb403bb8bea845e3fc5ebf,
title = "Multilevel regulation of autophagosome content by ethanol oxidation in HepG2 cells",
abstract = "Acute and chronic ethanol administration increase autophagic vacuole (i.e., autophagosome; AV) content in liver cells. This enhancement depends on ethanol oxidation. Here, we used parental (nonmetabolizing) and recombinant (ethanolmetabolizing) Hep G2 cells to identify the ethanol metabolite that causes AV enhancement by quantifying AVs or their marker protein, microtubule-associated protein 1 light chain 3-I (LC3-II). The ethanol-elicited rise in LC3-II was dependent on ethanol dose, was seen only in cells that expressed alcohol dehydrogenase (ADH) and was augmented in cells that coexpressed cytochrome CYP2E1 (P450 2E1). Furthermore, the rise in LC3-II was inversely related to a decline in proteasome activity. AV flux measurements and colocalization of AVs with lysosomes or their marker protein Lysosomal-Associated Membrane Protein 1 (LAMP1) in ethanol-metabolizing VL-17A cells (ADH+/CYP2E1+) revealed that ethanol exposure not only enhanced LC3-II synthesis but also decreased its degradation. Ethanol-induced accumulation of LC3-II in these cells was similar to that induced by the microtubule inhibitor, nocodazole. After we treated cells with either 4-methylpyrazole to block ethanol oxidation or GSH-EE to scavenge reactive species, there was no enhancement of LC3-II by ethanol. Furthermore, regardless of their ethanol-metabolizing capacity, direct exposure of cells to acetaldehyde enhanced LC3-II content. We conclude that both ADH-generated acetaldehyde and CYP2E1-generated primary and secondary oxidants caused LC3-II accumulation, which rose not only from enhanced AV biogenesis, but also from decreased LC3 degradation by the proteasome and by lysosomes.",
keywords = "Acetaldehyde, Alcohol dehydrogenase, Autophagy, Cytochrome P450 2E1, Lysosome, Oxidant stress",
author = "Thomes, {Paul G} and Ehlers, {Rebecca A.} and Trambly, {Casey S.} and Clemens, {Dahn L} and Fox, {Howard S} and Tuma, {Dean J.} and Terrence Donohue",
year = "2013",
month = "1",
doi = "10.4161/auto.22490",
language = "English (US)",
volume = "9",
pages = "63--73",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "1",

}

TY - JOUR

T1 - Multilevel regulation of autophagosome content by ethanol oxidation in HepG2 cells

AU - Thomes, Paul G

AU - Ehlers, Rebecca A.

AU - Trambly, Casey S.

AU - Clemens, Dahn L

AU - Fox, Howard S

AU - Tuma, Dean J.

AU - Donohue, Terrence

PY - 2013/1

Y1 - 2013/1

N2 - Acute and chronic ethanol administration increase autophagic vacuole (i.e., autophagosome; AV) content in liver cells. This enhancement depends on ethanol oxidation. Here, we used parental (nonmetabolizing) and recombinant (ethanolmetabolizing) Hep G2 cells to identify the ethanol metabolite that causes AV enhancement by quantifying AVs or their marker protein, microtubule-associated protein 1 light chain 3-I (LC3-II). The ethanol-elicited rise in LC3-II was dependent on ethanol dose, was seen only in cells that expressed alcohol dehydrogenase (ADH) and was augmented in cells that coexpressed cytochrome CYP2E1 (P450 2E1). Furthermore, the rise in LC3-II was inversely related to a decline in proteasome activity. AV flux measurements and colocalization of AVs with lysosomes or their marker protein Lysosomal-Associated Membrane Protein 1 (LAMP1) in ethanol-metabolizing VL-17A cells (ADH+/CYP2E1+) revealed that ethanol exposure not only enhanced LC3-II synthesis but also decreased its degradation. Ethanol-induced accumulation of LC3-II in these cells was similar to that induced by the microtubule inhibitor, nocodazole. After we treated cells with either 4-methylpyrazole to block ethanol oxidation or GSH-EE to scavenge reactive species, there was no enhancement of LC3-II by ethanol. Furthermore, regardless of their ethanol-metabolizing capacity, direct exposure of cells to acetaldehyde enhanced LC3-II content. We conclude that both ADH-generated acetaldehyde and CYP2E1-generated primary and secondary oxidants caused LC3-II accumulation, which rose not only from enhanced AV biogenesis, but also from decreased LC3 degradation by the proteasome and by lysosomes.

AB - Acute and chronic ethanol administration increase autophagic vacuole (i.e., autophagosome; AV) content in liver cells. This enhancement depends on ethanol oxidation. Here, we used parental (nonmetabolizing) and recombinant (ethanolmetabolizing) Hep G2 cells to identify the ethanol metabolite that causes AV enhancement by quantifying AVs or their marker protein, microtubule-associated protein 1 light chain 3-I (LC3-II). The ethanol-elicited rise in LC3-II was dependent on ethanol dose, was seen only in cells that expressed alcohol dehydrogenase (ADH) and was augmented in cells that coexpressed cytochrome CYP2E1 (P450 2E1). Furthermore, the rise in LC3-II was inversely related to a decline in proteasome activity. AV flux measurements and colocalization of AVs with lysosomes or their marker protein Lysosomal-Associated Membrane Protein 1 (LAMP1) in ethanol-metabolizing VL-17A cells (ADH+/CYP2E1+) revealed that ethanol exposure not only enhanced LC3-II synthesis but also decreased its degradation. Ethanol-induced accumulation of LC3-II in these cells was similar to that induced by the microtubule inhibitor, nocodazole. After we treated cells with either 4-methylpyrazole to block ethanol oxidation or GSH-EE to scavenge reactive species, there was no enhancement of LC3-II by ethanol. Furthermore, regardless of their ethanol-metabolizing capacity, direct exposure of cells to acetaldehyde enhanced LC3-II content. We conclude that both ADH-generated acetaldehyde and CYP2E1-generated primary and secondary oxidants caused LC3-II accumulation, which rose not only from enhanced AV biogenesis, but also from decreased LC3 degradation by the proteasome and by lysosomes.

KW - Acetaldehyde

KW - Alcohol dehydrogenase

KW - Autophagy

KW - Cytochrome P450 2E1

KW - Lysosome

KW - Oxidant stress

UR - http://www.scopus.com/inward/record.url?scp=84872191827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872191827&partnerID=8YFLogxK

U2 - 10.4161/auto.22490

DO - 10.4161/auto.22490

M3 - Article

C2 - 23090141

AN - SCOPUS:84872191827

VL - 9

SP - 63

EP - 73

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 1

ER -